Renal Cancer - Results from #2880

Changes in therapy and survival of metastatic renal cell carcinoma in Estonia. March 27, 2020

Sex-specific analysis of renal cell carcinoma histology and survival in Japan: A population-based study 2004 to 2016. March 27, 2020

Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets. March 26, 2020

Differential expression analysis of clear cell renal cell carcinomas in THE CANCER GENOME ATLAS distinguishes an aggressive subset enriched with chromosome 7 and 12 gains. March 26, 2020

Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer. March 26, 2020

Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study. March 26, 2020

Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney. March 25, 2020

The Association between Chronic Conditions, End-of-Life Health Care Use, and Documentation of Advance Care Planning among Patients with Cancer. March 25, 2020

Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease. March 25, 2020

Oncological and functional outcomes of open versus laparoscopic partial nephrectomy in T1b tumors: A single-center analysis. March 25, 2020

Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma. March 24, 2020

A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma. March 24, 2020

Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study. March 24, 2020

Components of one-carbon metabolism and renal cell carcinoma: a systematic review and meta-analysis. March 24, 2020

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies. March 24, 2020

Histologic Subtype, Tumor Grade, Tumor Size, and Race Can Accurately Predict the Probability of Synchronous Metastases in T2 Renal Cell Carcinoma. March 23, 2020

An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC). March 23, 2020

Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-Analysis. March 23, 2020

Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis. March 23, 2020

Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma. March 20, 2020

Page 145 of 456